Functional Characterization of Domains of IPS-1 Using an Inducible Oligomerization System

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Takamatsu, Shiori ^a   Onoguchi, Kazuhide ^a   Onomoto, Koji ^b   Narita, Ryo ^a   Takahasi, Kiyohiro ^a   Ishidate, Fumiyoshi ^c   Fujiwara, Takahiro K ^c   Yoneyama, Mitsutoshi ^b   Kato, Hiroki ^a   Fujita, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; INTERFERON BETA PROMOTER STIMULATOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DEAD-BOX RNA HELICASES; FIBROBLASTS; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; MICE; NEWCASTLE DISEASE VIRUS; NF-KAPPA B; OLIGOPEPTIDES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

IPS;

EID: 84872163861     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053578     Document Type: Article

References (35)

1. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737.
2. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858.
3. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
4. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
5. Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, et al. (2007) Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282: 7576-7581.
6. Sambhara S, Fujita T (2012) Nucleic Acid Sensors and Antiviral Immunity. Austin (TX): Landes Bioscience.
7. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
8. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
9. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
10. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740.
11. Onoguchi K, Onomoto K, Takamatsu S, Jogi M, Takemura A, et al. (2010) Virus-infection or 5′ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 6: e1001012.
12. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, et al. (2011) MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146: 448-461.
13. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ, (2005) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102: 17717-17722.
14. Tang ED, Wang CY, (2009) MAVS self-association mediates antiviral innate immune signaling. J Virol 83: 3420-3428.
15. Tang ED, Wang CY, (2010) TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. PLoS One 5: e9172.
16. Saha SK, Pietras EM, He JQ, Kang JR, Liu SY, et al. (2006) Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25: 3257-3263.
17. Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, et al. (1998) Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci U S A 95: 10437-10442.
18. Ouda R, Onomoto K, Takahasi K, Edwards MR, Kato H, et al. (2011) Retinoic acid-inducible gene I-inducible miR-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor. J Biol Chem 286: 26210-26219.
19. Yoneyama M, Fujita T, (2010) Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20: 4-22.
20. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, et al. (2002) Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418: 443-447.
21. Ueyama T, Kusakabe T, Karasawa S, Kawasaki T, Shimizu A, et al. (2008) Sequential binding of cytosolic Phox complex to phagosomes through regulated adaptor proteins: evaluation using the novel monomeric Kusabira-Green System and live imaging of phagocytosis. J Immunol 181: 629-640.
22. Belgnaoui SM, Paz S, Hiscott J, (2011) Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 23: 564-572.
23. Koshiba T (2012) Mitochondrial-mediated antiviral immunity. Biochim Biophys Acta.
24. Lin R, Heylbroeck C, Pitha PM, Hiscott J, (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18: 2986-2996.
25. Mao AP, Li S, Zhong B, Li Y, Yan J, et al. (2010) Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J Biol Chem 285: 9470-9476.
26. Paz S, Vilasco M, Arguello M, Sun Q, Lacoste J, et al. (2009) Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Mol Cell Biol 29: 3401-3412.
27. Shirane M, Nakayama KI, (2003) Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5: 28-37.
28. Paz S, Vilasco M, Werden SJ, Arguello M, Joseph-Pillai D, et al. (2011) A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res 21: 895-910.
29. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, et al. (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature 439: 208-211.
30. Yoshida R, Takaesu G, Yoshida H, Okamoto F, Yoshioka T, et al. (2008) TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J Biol Chem 283: 36211-36220.
31. Poeck H, Bscheider M, Gross O, Finger K, Roth S, et al. (2010) Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 11: 63-69.
32. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, et al. (1998) Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17: 1087-1095.
33. Daly C, Reich NC, (1993) Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol Cell Biol 13: 3756-3764.
34. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, et al. (2006) Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203: 1795-1803.
35. Iwamura T, Yoneyama M, Yamaguchi K, Suhara W, Mori W, et al. (2001) Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6: 375-388.